ArticleFrontiers in pediatrics2026
Case Report: First case of Triple A syndrome diagnosed in French Guiana: clinical presentation, molecular confirmation, and literature review.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Triple A syndrome (OMIM #231550) is a rare autosomal recessive disorder defined by the triad of alacrima, adrenal insufficiency, and achalasia. Around 100 to 150 cases have been reported in the world literature since 1978. We report the first case diagnosed in French Guiana, in a 5-year-old boy who presented with severe hypoglycemic episodes. Exome sequencing identified a homozygous pathogenic variant in the AAAS gene (NM_015665.6:c.43C > A, p.Gln15Lys - ACMG Class 5). Family testing confirmed heterozygous carrier status in both parents, while the younger brother was found to be homozygous wild-type and unaffected. The clinical course under hydrocortisone replacement has been favorable. A literature review and comparative analysis are presented to place this case in context and to highlight the phenotypic and molecular variability of the syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.